Lactate induces metabolic and epigenetic reprogramming of pro-inflammatory Th17 cells

Aleksandra Lopez Krol,Hannah P Nehring,Felix F Krause,Anne Wempe,Hartmann Raifer,Andrea Nist,Thorsten Stiewe,Wilhelm Bertrams,Bernd Schmeck,Maik Luu,Hanna Leister,Ho-Ryun Chung,Uta-Maria Bauer,Till Adhikary,Alexander Visekruna
DOI: https://doi.org/10.15252/embr.202254685
2022-12-06
Abstract:Increased lactate levels in the tissue microenvironment are a well-known feature of chronic inflammation. However, the role of lactate in regulating T cell function remains controversial. Here, we demonstrate that extracellular lactate predominantly induces deregulation of the Th17-specific gene expression program by modulating the metabolic and epigenetic status of Th17 cells. Following lactate treatment, Th17 cells significantly reduced their IL-17A production and upregulated Foxp3 expression through ROS-driven IL-2 secretion. Moreover, we observed increased levels of genome-wide histone H3K18 lactylation, a recently described marker for active chromatin in macrophages, in lactate-treated Th17 cells. In addition, we show that high lactate concentrations suppress Th17 pathogenicity during intestinal inflammation in mice. These results indicate that lactate is capable of reprogramming pro-inflammatory T cell phenotypes into regulatory T cells.
What problem does this paper attempt to address?